注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
Solid Biosciences Inc是一家生命科學公司。該公司專注於開髮變革性治療,以改善Duchenne肌營養不良症(Duchenne)患者的生活。Duchenne是一種遺傳性肌肉萎縮疾病,主要影響男孩。SGT-001和SGT-003是其基因轉移候選產品。SGT-001和SGT-003旨在通過傳遞一種合成的轉基因來解決Duchenne的潛在遺傳原因,該轉基因可產生僅在身體肌肉(包括心肌和呼吸肌)中表達的肌營養不良蛋白樣蛋白。SGT-001是其主要基因轉移候選基因,利用腺相關病毒(AAV)9載體。除了候選基因轉移外,該公司還制定了專注於平台技術的開發計劃,包括雙基因表達,這項技術允許它將多個轉基因包裝到一個載體以及衣殼中。它正在開發SGT-001,用於通過單次靜脈給藥治療Duchenne。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Ian F. Smith | 57 | 2020 | Executive Chair |
Adam Leo Stone | 43 | 2015 | Lead Independent Director |
Lynne Marie Sullivan | 56 | 2015 | Independent Director |
Jeffrey Chamberlain | - | 2018 | Chairman of Scientific Advisory Board |
Rajeev Shah | 46 | 2017 | Independent Director |
Ilan Ganot | 49 | 2013 | Co-founder, Strategic Advisor to the CEO & Director |
Alexander G. Cumbo | 52 | 2022 | President, CEO & Director |
Laurence A. Turka | 65 | - | Member of Scientific Advisory Board |
Michael W. Lawlor | - | - | Member of Scientific Advisory Board |
Sukumar Nagendran | 56 | 2018 | Independent Director |
Geoffrey F. Slaff | - | - | Member of Scientific Advisory Board |
Carrie Miceli | - | - | Member of Scientific Advisory Board |
Jeffrey A. Bluestone | 70 | - | Member of Scientific Advisory Board |
Clare Kahn | 71 | 2021 | Independent Director |
Martin I. Freed | 62 | 2018 | Independent Director |
Lee Sweeney | - | - | Member of Scientific Advisory Board |
Georgia Keresty | 61 | 2021 | Independent Director |
Ronald D. Cohn | - | - | Member of Scientific Advisory Board |
Dongsheng Duan | - | - | Member of Scientific Advisory Board |
Joe Kornegay | - | - | Member of the Scientific Advisory Board |
Adam M. Koppel | 54 | 2022 | Independent Director |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核